Our results correspond to other previous observations that chemotherapeutic agents can enhance TRAIL-induced apoptosis in human cancers such as breast cancer [41,42], squamous carcinoma [43], colon cancer [44], renal carcinoma, bladder cancer, lung cancer and prostate cancer [45,46]. Here, TNFSF10 is linked to prostate cancer.